Month: June 2025

●Research and Development initiatives underscore companies’ commitment to co-developing new cooling, power, building management and control systems for digital and physical AI data centers●Partnership will underpin Europe’s AI infrastructure ambitions, aligning with the EU Commission’s ‘AI Continent Action Plan’ and its ‘InvestAI’ initiative●Schneider Electric announces launch of new NVIDIA-enabled rack solutionSchneider-Electric_NVIDIA.jpgSchneider-Electric_NVIDIA.jpgParis, France, June 11, 2025 (GLOBE NEWSWIRE) — PARIS (NVIDIA GTC), June 11, 2025 – Schneider Electric, the leader in the digital transformation of energy management and automation, today announced it is collaborating with NVIDIA to serve the growing demand for sustainable, AI-ready infrastructure. Together, Schneider Electric and NVIDIA are advancing research...

Mag Mile Capital, IncIndy ClosingChicago, Illinois, June 11, 2025 (GLOBE NEWSWIRE) — Mag Mile Capital, Inc. (OTCQB: MMCP) (“Mag Mile”, or the “Company”) is pleased to announce the successful closing of $9.75 million in cash out CMBS financing for the Holiday Inn at Indianapolis Airport, a premium hotel located in Indianapolis, Indiana. The financing was structured with a 60% loan-to-value (LTV) ratio, a 5-year loan term, and a 30-year amortization schedule. The limited-recourse loan closed in May 2025. The CMBS loan was funded by a large New York based non-bank lender that is one of Mag Mile Capital’s premier relationships in the capital markets. Rushi Shah, Chairman and CEO of Mag Mile spearheaded the transaction along with support from Prabhat Jayara, Senior Vice President of Originations. This...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle meeting recently completed with no significant issues or major deficiencies; late-cycle meeting planned for mid-July Biologics License Application remains under priority review with PDUFA target action date of August 31, 2025SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the successful completion of the U.S. Food and Drug Administration’s (FDA) Pre-License Inspection (PLI) of its San Diego manufacturing facility for Deramiocel, the Company’s lead cell therapy candidate...

Sending a correction due to mistake in the Meeting’s accounting day – 23 June 2025On 1 July 2025, the ordinary general meeting of shareholders (the Meeting) of Public limited liability company “Novaturas”, code 135567698, registered at A. Mickevičiaus str. 27, Kaunas, the Republic of Lithuania (the Company), is being convened upon the initiative and decision of the Board of the Company. The place of the Meeting (address): J. Jasinskio st. 16 C, Vilnius, Lithuania, Conference Centre, hall B. Start of the Meeting: the Meeting starts at 10:00 a.m. (registration of shareholders starts at 9:00 a.m.). The Meeting’s accounting day – 23 June 2025. Only persons who are shareholders of the Company at the end of accounting day of the Meeting or persons authorized by them, or persons with whom shareholders concluded the agreements on...

ROSEVILLE, Minn, June 11, 2025 (GLOBE NEWSWIRE) — – Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the CJS Securities 25th Annual New Ideas Summer Conference on July 10, 2025. The conference will be held at the Metropolis Country Club in White Plains, NY. The conference will be attended by a group of targeted institutional investors, where each company in attendance will have a presentation slot and will be available for one-on-one meetings. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinators or Hawkins Investor Relations at ir@hawkinsinc.com. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company...

— Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® — ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products announces a partnership with Carolinas Fertility Institute (CFI), one of America’s best fertility clinics. Carolinas Fertility Institute will provide the Company’s FemaSeed® intratubal insemination product as an infertility treatment option to patients throughout its network in North Carolina. “Our partnership with Carolinas Fertility Institute reflects the growing momentum behind FemaSeed as a meaningful first-line fertility solution,” said Kathy...

AppFolio Realm-X Performers enable agentic operations across complex workflows, delivering outcomes and a better experience for residents, property managers, owners, and investorsAppFolio Realm-X Performers enable agentic operations across complex workflows, delivering outcomes and a better experience for residents, property managers, owners, and investorsLAS VEGAS, June 11, 2025 (GLOBE NEWSWIRE) — AppFolio (NASDAQ:APPF), the technology leader powering the future of the real estate industry, announced its latest innovations at NAA Apartmentalize 2025, including the next evolution of AppFolio Realm-X – its embedded generative AI – through the introduction of Realm-X Performers, designed to automate complex workflows through advanced agentic operations. According to the 2025 AppFolio Property Management Benchmark...

BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will present a corporate overview at the upcoming 2025 BIO International Convention taking place in Boston, MA from June 16 – 19, 2025. Dr. Mazzo’s presentation is scheduled for Tuesday, June 17th at 11:15 a.m. Eastern Time in Room 153A. To register for the conference and schedule a one-on-one meeting with Lisata’s management, please visit https://www.bio.org/events/bio-international-convention/registration. About Lisata Therapeutics Lisata Therapeutics is a clinical-stage pharmaceutical...